Journal
CANCER CELL
Volume 23, Issue 1, Pages 107-120Publisher
CELL PRESS
DOI: 10.1016/j.ccr.2012.11.013
Keywords
-
Categories
Funding
- NIH [R37GM043880, R01CA61774, U19A1077435, K12HD055881, T32HL094290, P30CA16059]
- Cure Research Foundation
- NINDS Center core grant [5P30NS047463]
Ask authors/readers for more resources
Inflammatory bowel disease is an important risk factor for colorectal cancer. We show that sphingosine-1-phosphate (SIP) produced by upregulation of sphingosine kinase 1 (SphK1) links chronic intestinal inflammation to colitis-associated cancer (CAC) and both are exacerbated by deletion of Sphk2. SIP is essential for production of the multifunctional NF-kappa B-regulated cytokine IL-6, persistent activation of the transcription factor STAT3, and consequent upregulation of the Si P receptor, 51PR1. The prodrug FTY720 decreased SphK1 and S1PR1 expression and eliminated the NF-kappa B/IL-6/STAT3 amplification cascade and development of CAC, even in Sphk2(-/-) mice, and may be useful in treating colon cancer in individuals with ulcerative colitis. Thus, the SphK1/S1P/S1PR1 axis is at the nexus between NF-kappa B and STAT3 and connects chronic inflammation and CAC.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available